2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

ODM-104 and optimized carbidopa dose show beneficial effect on levodopa PK in healthy subjects

J. Tuunainen, J. Ellmén, M. Vahteristo, A. Holopainen, D. Strugala (Espoo, Finland)
Odor identification in PD patients and controls in Estonian cohort

I. Kalju, T. Toomsoo, K. Vender (Tallinn, Estonia)
Off-painfull state in Parkinson’s disease patients: A redflag of complulsive behavior. Data from a PET-FDG study

G. Albani, A. Cistaro, P. Fania, S. Margotti, V. Arena, A. Mauro (Verbania, Italy)
Olfactory dysfunction predicting cognition

X. Yu (Cleveland, OH, USA)
Olfactory dysfunction, sleep disturbances, neuronal loss, and regional brain atrophy in an inducible mouse model of Alpha-Synucleinopathy

E. Brison, S. Zehntner, A. Zijdenbos, K. Luk, B. Bedell (Montreal, QC, Canada)
Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A cross-sectional study amongst patients in a tertiary movement center

S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)
Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

K. Ohta, T. Nakajima (Niigata, Japan)
Olfactory testing in Parkinson plus syndromes

O. Abdukarimov, F. Akhmedova (Tashkent, Uzbekistan)
Oligosymptomatic Fahr’s syndrome (2 clinical cases)

Y. Solodovnikova (Odessa, Ukraine)
On Converting Patients From Oral Dopamine Agonists to the Carbidopa/Levodopa Enteral Suspension Method – Real World Conversion Ratios

S. Nakano, L. Bahroo, F. Pagan, F. Amjad, S. Lo, I. Gambhir (Washington, D.C., DC, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z